Vita Life Sciences Limited. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vita Life Sciences Limited. with three other
pharmaceutical manufacturers in Australasia:
Cann Global Ltd
(2018
sales of 3.87 million Australian Dollars [US$2.64 million]
),
AFT Pharmaceuticals Ltd
of New Zealand
(80.07 million New Zealand Dollars [US$52.44 million]
of which 61%
was Australia), and
Probiotec Limited
(75.72 million Australian Dollars [US$51.65 million]
).
Sales Analysis.
Vita Life Sciences Limited. reported sales of A$41.15 million (US$28.07 million)
for the
year ending
December of 2018.
This
represents
an
increase of 9.0%
versus 2017, when the company's sales were A$37.74 million.